Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Nonalcoholic Fatty Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Large-scale testing (Phase 3)Study completedNCT02242149
What this trial is testing

Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease
Universidade Federal do Rio de Janeiro 84
Not applicableEnded earlyNCT01260246
What this trial is testing

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Steatohepatitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12
Post-approval studies (Phase 4)UnknownNCT04976283
What this trial is testing

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic SteatohepatitisNAFLD
Getz Pharma 123
Not applicableEnded earlyNCT01855386
What this trial is testing

The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

Who this might be right for
Gestational Diabetes Mellitus in Pregnancy
University of Florida 126
Large-scale testing (Phase 3)UnknownNCT03970031
What this trial is testing

MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Who this might be right for
Type2 DiabetesNASH - Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis+1 more
Cirius Therapeutics, Inc. 1,800
Early research (Phase 1)Looking for participantsNCT06694935
What this trial is testing

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Non-Alcoholic Fatty Liver Disease (NAFLD)
1Globe Health Institute 52
Not applicableStudy completedNCT03165877
What this trial is testing

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Universidad de Valparaiso 13
Not applicableStudy completedNCT04241575
What this trial is testing

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Chinese University of Hong Kong 1,061
Not applicableStudy completedNCT07338331
What this trial is testing

Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabete Type 2Non Alcoholic Fatty Liver
Galala University 80
Not applicableLooking for participantsNCT05165706
What this trial is testing

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2PreDiabetesInsulin Resistance+4 more
Stanford University 110
Post-approval studies (Phase 4)UnknownNCT02964715
What this trial is testing

The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLD
University of Malaya 25
Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51
Not applicableUnknownNCT02609243
What this trial is testing

Diabetes Nutrition Algorithm - Prediabetes

Who this might be right for
PrediabetesDiabetes Mellitus Type 2Obesity+2 more
German Institute of Human Nutrition 250
Not applicableLooking for participantsNCT05697991
What this trial is testing

Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
King Saud University 1,000
Early research (Phase 1)Study completedNCT00862433
What this trial is testing

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Who this might be right for
DiabetesFatty LiverObesity+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableStudy completedNCT04527965
What this trial is testing

Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes

Who this might be right for
NAFLDDiabetes Mellitus, Type 2PreDiabetes
Uppsala University 150
Not applicableUnknownNCT02248311
What this trial is testing

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Who this might be right for
Type2 Diabetes MellitusMicroangiopathyNon Alcoholic Fatty Liver Disease+4 more
Hospital Universitari Vall d'Hebron Research Institute 260
Next Page